PPARG and non-small cell lung carcinoma: In addition, treatment of human NSCLC lines with PPARγ ligands resulted in growth arrest, loss of capacity for anchorage-independent growth, and decreased activity and expression of matrix metalloproteinase (MMP) 2 [44], as well as apoptosis induction [23, 45, 46].